Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells

  • Authors:
    • Yaodong Zhang
    • Shixin Ding
    • Yali Chen
    • Zhenghao Sun
    • Junyan Zhang
    • Yuli Han
    • Xianan Dong
    • Zhirui Fang
    • Weizu Li
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacy, The First People's Hospital of Xiaoshan District, Hangzhou, Zhejiang 311200, P.R. China, Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti‑inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 782
    |
    Published online on: May 19, 2021
       https://doi.org/10.3892/etm.2021.10214
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lipopolysaccharide (LPS) is a toxic component of cell walls of Gram‑negative bacteria that are widely present in gastrointestinal tracts. Increasing evidence showed that LPS plays important roles in the pathogeneses of neurodegenerative disorders, such as Alzheimer's disease (AD). NADPH oxidase s2 (NOX2) is a complex membrane protein that contributes to the production of reactive oxygen species (ROS) in several neurological diseases. The NLRP1 inflammasome can be activated in response to an accumulation of ROS in neurons. However, it is still unknown whether LPS exposure can deteriorate neuronal damage by activating NOX2‑NLRP1 inflammasomes. Ginsenoside Rg1 (Rg1) has protective effects on neurons, although whether Rg1 alleviates LPS‑induced neuronal damage by inhibiting NOX2‑NLRP1 inflammasomes remains unclear. In the present study, the effect of concentration gradients and different times of LPS exposure on neuronal damage was investigated in HT22 cells, and further observed the effect of Rg1 treatment on NOX2‑NLPR1 inflammasome activation, ROS production and neuronal damage in LPS‑treated HT22 cells. The results demonstrated that LPS exposure significantly induced NOX2‑NLRP1 inflammasome activation, excessive production of ROS, and neuronal damage in HT22 cells. It was also shown that Rg1 treatment significantly decreased NOX2‑NLRP1 inflammasome activation and ROS production and alleviated neuronal damage in LPS‑induced HT22 cells. The present data suggested that Rg1 has protective effects on LPS‑induced neuronal damage by inhibiting NOX2‑NLRP1 inflammasomes in HT22 cells, and Rg1 may be a potential therapeutic approach for delaying neuronal damage in AD.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Freeman LC and Ting JP: The pathogenic role of the inflammasome in neurodegenerative diseases. J Neurochem. 136 (Suppl 1):S29–S38. 2016.PubMed/NCBI View Article : Google Scholar

2 

Boutajangout A, Lindberg H, Awwad A, Paul A, Baitalmal R, Almokyad I, Höidén-Guthenberg I, Gunneriusson E, Frejd FY, Härd T, et al: Affibody-mediated sequestration of amyloid β demonstrates preventive efficacy in a transgenic Alzheimer's disease mouse model. Front Aging Neurosci. 11(64)2019.PubMed/NCBI View Article : Google Scholar

3 

Zhan X, Stamova B, Jin LW, DeCarli C, Phinney B and Sharp FR: Gram-negative bacterial molecules associate with Alzheimer disease pathology. Neurology. 87:2324–2332. 2016.PubMed/NCBI View Article : Google Scholar

4 

Zhao Y, Jaber V and Lukiw WJ: Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): Detection of lipopolysaccharide (LPS) in AD hippocampus. Front Cell Infect Microbiol. 7(318)2017.PubMed/NCBI View Article : Google Scholar

5 

Ju IG, Choi JG, Kim N, Kwak C, Lee JK and Oh MS: Peucedani Japonici Radix ameliorates lipopolysaccharide-induced neuroinflammation by regulating microglial responses. Neurosci Lett. 686:161–167. 2018.PubMed/NCBI View Article : Google Scholar

6 

Zhou J, Yu W, Zhang M, Tian X, Li Y and Lü Y: Imbalance of microglial TLR4/TREM2 in LPS-treated APP/PS1 transgenic mice: A potential link between Alzheimer's disease and systemic inflammation. Neurochem Res. 44:1138–1151. 2019.PubMed/NCBI View Article : Google Scholar

7 

You LH, Yan CZ, Zheng BJ, Ci YZ, Chang SY, Yu P, Gao GF, Li HY, Dong TY and Chang YZ: Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis. Cell Death Dis. 8(e2676)2017.PubMed/NCBI View Article : Google Scholar

8 

Ji YF, Wang D, Liu YR, Ma XR, Lu H and Zhang BA: MicroRNA-132 attenuates LPS-induced inflammatory injury by targeting TRAF6 in neuronal cell line HT-22. J Cell Biochem. 119:5528–5537. 2018.PubMed/NCBI View Article : Google Scholar

9 

Christensen LP and Christensen KB: The role of direct and indirect polyphenolic antioxidants in protection against oxidative stress. In: Polyphenols in Human Health and Disease. Watson RR, Preedy VR and Zibadi S (eds). Academic Press, San Diego, CA, pp289-309, 2014.

10 

Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA and Ganie SA: Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 74:101–110. 2015.PubMed/NCBI View Article : Google Scholar

11 

Dasoveanu DC, Park HJ, Ly CL, Shipman WD, Chyou S, Kumar V, Tarlinton D, Ludewig B, Mehrara BJ and Lu TT: Lymph node stromal CCL2 limits antibody responses. Sci Immunol. 5(eaaw0693)2020.PubMed/NCBI View Article : Google Scholar

12 

d'Avila JC, Siqueira LD, Mazeraud A, Azevedo EP, Foguel D, Castro-Faria-Neto HC, Sharshar T, Chrétien F and Bozza FA: Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation. J Neuroinflammation. 15(28)2018.PubMed/NCBI View Article : Google Scholar

13 

Fan LM, Cahill-Smith S, Geng L, Du J, Brooks G and Li JM: Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function. Free Radic Biol Med. 108:940–951. 2017.PubMed/NCBI View Article : Google Scholar

14 

Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA and Boche D: Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization. Brain. 136:2677–2696. 2013.PubMed/NCBI View Article : Google Scholar

15 

Abulafia DP, de Rivero Vaccari JP, Lozano JD, Lotocki G, Keane RW and Dietrich WD: Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab. 29:534–544. 2009.PubMed/NCBI View Article : Google Scholar

16 

Ma MW, Wang J, Dhandapani KM and Brann DW: NADPH oxidase 2 regulates NLRP3 inflammasome activation in the brain after traumatic brain injury. Oxid Med Cell Longev. 2017(6057609)2017.PubMed/NCBI View Article : Google Scholar

17 

Xu T, Sun L, Shen X, Chen Y, Yin Y, Zhang J, Huang D and Li W and Li W: NADPH oxidase 2-mediated NLRP1 inflammasome activation involves in neuronal senescence in hippocampal neurons in vitro. Int Immunopharmacol. 69:60–70. 2019.PubMed/NCBI View Article : Google Scholar

18 

Qiu Z, He Y, Ming H, Lei S, Leng Y and Xia ZY: Lipopo-lysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019(8151836)2019.PubMed/NCBI View Article : Google Scholar

19 

Xiao Q, Zhang S, Ren H, Du R, Li J, Zhao J, Gao Y, Zhu Y and Huang W: Ginsenoside Rg1 alleviates ANIT-induced intrahepatic cholestasis in rats via activating farnesoid X receptor and regulating transporters and metabolic enzymes. Chem Biol Interact. 324(109062)2020.PubMed/NCBI View Article : Google Scholar

20 

Zhu G, Wang Y, Li J and Wang J: Chronic treatment with ginsenoside Rg1 promotes memory and hippocampal long-term potentiation in middle-aged mice. Neuroscience. 292:81–89. 2015.PubMed/NCBI View Article : Google Scholar

21 

Zhang YQ, Wang XB, Xue RR, Gao XX and Li W: Ginsenoside Rg1 attenuates chronic unpredictable mild stress-induced depressive-like effect via regulating NF-κB/NLRP3 pathway in rats. Neuroreport. 30:893–900. 2019.PubMed/NCBI View Article : Google Scholar

22 

Giuliani C: The flavonoid quercetin induces AP-1 activation in FRTL-5 thyroid cells. Antioxidants. 8(112)2019.PubMed/NCBI View Article : Google Scholar

23 

Chen Y, Ding S, Zhang H, Sun Z, Shen X, Sun L, Yin Y, Qun S and Li W: Protective effects of ginsenoside Rg1 on neuronal senescence due to inhibition of NOX2 and NLRP1 inflammasome activation in SAMP8 mice. J Funct Foods. 65(103713)2020.

24 

Jin Y, Peng J, Wang X, Zhang D and Wang T: Ameliorative effect of ginsenoside Rg1 on lipopolysaccharide-induced cognitive impairment: Role of cholinergic system. Neurochem Res. 42:1299–1307. 2017.PubMed/NCBI View Article : Google Scholar

25 

Crupi R, Impellizzeri D, Gugliandolo E, Cordaro M, Siracusa R, Britti D, Cuzzocrea S and Di Paola R: Effect of tempol, a membrane-permeable free radical scavenger, on in vitro model of eye inflammation on rabbit corneal cells. J Ocul Pharmacol Ther. 35:571–577. 2019.PubMed/NCBI View Article : Google Scholar

26 

Li M, Liu Z, Zhuan L, Wang T, Guo S, Wang S, Liu J and Ye Z: Effects of apocynin on oxidative stress and expression of apoptosis-related genes in testes of diabetic rats. Mol Med Rep. 7:47–52. 2013.PubMed/NCBI View Article : Google Scholar

27 

Shen X, Dong X, Han Y, Li Y, Ding S, Zhang H, Sun Z, Yin Y and Li W and Li W: Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int Immunopharmacol. 82(106339)2020.PubMed/NCBI View Article : Google Scholar

28 

Liu J, Li L and Suo WZ: HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sci. 84:267–271. 2009.PubMed/NCBI View Article : Google Scholar

29 

El-Far AH, Darwish NHE and Mousa SA: Senescent colon and breast cancer cells induced by doxorubicin exhibit enhanced sensitivity to curcumin, caffeine, and thymoquinone. Integr Cancer Ther. 19(1534735419901160)2020.PubMed/NCBI View Article : Google Scholar

30 

Xu TZ, Shen XY, Sun LL, Chen YL, Zhang BQ, Huang DK and Li WZ: Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro. Int J Mol Med. 43:717–726. 2019.PubMed/NCBI View Article : Google Scholar

31 

Zong Y, Ai QL, Zhong LM, Dai JN, Yang P, He Y, Sun J, Ling EA and Lu D: Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory responses via the phospholipase C-γ1 signaling pathway in murine BV-2 microglial cells. Curr Med Chem. 19:770–779. 2012.PubMed/NCBI View Article : Google Scholar

32 

Zanoni I, Bodio C, Broggi A, Ostuni R, Caccia M, Collini M, Venkatesh A, Spreafico R, Capuano G and Granucci F: Similarities and differences of innate immune responses elicited by smooth and rough LPS. Immunol Lett. 142:41–47. 2012.PubMed/NCBI View Article : Google Scholar

33 

Catorce MN and Gevorkian G: LPS-induced murine neuroinflammation model: Main features and suitability for pre-clinical assessment of nutraceuticals. Curr Neuropharmacol. 14:155–164. 2016.PubMed/NCBI View Article : Google Scholar

34 

Lopes PC: LPS and neuroinflammation: A matter of timing. Inflammopharmacology. 24:291–293. 2016.PubMed/NCBI View Article : Google Scholar

35 

Xu C, Hou B, He P, Ma P, Yang X, Yang X, Zhang L, Qiang G, Li W and Du G: Neuroprotective effect of salvianolic acid A against diabetic peripheral neuropathy through modulation of Nrf2. Oxid Med Cell Longev. 2020(6431459)2020.PubMed/NCBI View Article : Google Scholar

36 

Velagapudi R, El-Bakoush A and Olajide OA: Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside. Mol Neurobiol. 55:8103–8123. 2018.PubMed/NCBI View Article : Google Scholar

37 

Wan JZ, Wang R, Zhou ZY, Deng LL, Zhang CC, Liu CQ, Zhao HX, Yuan CF, He YM, Dun YY, et al: Saponins of Panax japonicus attenuate neuronal apoptosis through oxidative stress-related pathways and autophagy in natural aging rats. Curr Pharm Biotechnol. 21:2019.PubMed/NCBI View Article : Google Scholar

38 

Wu J, Pan Z, Wang Z, Zhu W, Shen Y, Cui R, Lin J, Yu H, Wang Q, Qian J, et al: Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway. Neuropharmacology. 63:349–361. 2012.PubMed/NCBI View Article : Google Scholar

39 

Ma J, Liu J, Wang Q, Yu H, Chen Y and Xiang L: The beneficial effect of ginsenoside Rg1 on Schwann cells subjected to hydrogen peroxide induced oxidative injury. Int J Biol Sci. 9:624–636. 2013.PubMed/NCBI View Article : Google Scholar

40 

Xiang Y, Wang SH, Wang L, Wang ZL, Yao H, Chen LB and Wang YP: Effects of ginsenoside Rg1 regulating Wnt/β-catenin signaling on neural stem cells to delay brain senescence. Stem Cells Int. 2019(5010184)2019.PubMed/NCBI View Article : Google Scholar

41 

Liu JQ, Zhao M, Zhang Z, Cui LY, Zhou X, Zhang W, Chu SF, Zhang DY and Chen NH: Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization. Acta Pharmacol Sin. 41:523–534. 2020.PubMed/NCBI View Article : Google Scholar

42 

Xu J and Wei X, Gao F, Zhong X, Guo R, Ji Y, Zhou X, Chen J, Yao P, Liu X and Wei X: Nicotinamide adenine dinucleotide phosphate oxidase 2-derived reactive oxygen species contribute to long-term potentiation of C-fiber-evoked field potentials in spinal dorsal horn and persistent mirror-image pain following high-frequency stimulus of the sciatic nerve. Pain. 161:758–772. 2020.PubMed/NCBI View Article : Google Scholar

43 

Wang Y, Lv W, Li Y, Liu D, He X and Liu T: Ampelopsin improves cognitive impairment in Alzheimer's disease and effects of inflammatory cytokines and oxidative stress in the hippocampus. Curr Alzheimer Res. 17:44–51. 2019.PubMed/NCBI View Article : Google Scholar

44 

Chen XH, Zhou X, Yang XY, Zhou ZB, Lu DH, Tang Y, Ling ZM, Zhou LH and Feng X: Propofol protects against H2O2-induced oxidative injury in differentiated PC12 cells via inhibition of Ca(2+)-dependent NADPH oxidase. Cell Mol Neurobiol. 36:541–551. 2016.PubMed/NCBI View Article : Google Scholar

45 

Sun L, Chen Y, Shen X, Xu T, Yin Y, Zhang H, Ding S, Zhao Y, Zhang Y, Guan Y and Li W: Inhibition of NOX2-NLRP1 signaling pathway protects against chronic glucocorticoids exposure-induced hippocampal neuronal damage. Int Immunopharmacol. 74(105721)2019.PubMed/NCBI View Article : Google Scholar

46 

Tenkorang MAA, Duong P and Cunningham RL: NADPH oxidase mediates membrane androgen receptor-induced neurodegeneration. Endocrinology. 160:947–963. 2019.PubMed/NCBI View Article : Google Scholar

47 

Zhao Y, Fan C, Zhang A, Zhang Y, Wang F, Weng Q and Xu M: Walnut polyphenol extract protects against Malathion- and chlorpyrifos-induced immunotoxicity by modulating TLRx-NOX-ROS. Nutrients. 12(616)2020.PubMed/NCBI View Article : Google Scholar

48 

Liu L and Chan C: The role of inflammasome in Alzheimer's disease. Ageing Res Rev. 15:6–15. 2014.PubMed/NCBI View Article : Google Scholar

49 

Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H and Yang XF: Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol. 22:311–322. 2009.PubMed/NCBI View Article : Google Scholar

50 

Tan CC, Zhang JG, Tan MS, Chen H, Meng DW, Jiang T, Meng XF, Li Y, Sun Z, Li MM, et al: NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model. J Neuroinflammation. 12(18)2015.PubMed/NCBI View Article : Google Scholar

51 

de Rivero Vaccari JP, Dietrich WD and Keane RW: Therapeutics targeting the inflammasome after central nervous system injury. Transl Res. 167:35–45. 2016.PubMed/NCBI View Article : Google Scholar

52 

Martins JD, Liberal J, Silva A, Ferreira I, Neves BM and Cruz MT: Autophagy and inflammasome interplay. DNA Cell Biol. 34:274–281. 2015.PubMed/NCBI View Article : Google Scholar

53 

Gao Q and Zhu H: The overexpression of sirtuin1 (SIRT1) alleviated lipopolysaccharide (LPS)-induced acute kidney injury (AKI) via inhibiting the activation of nucleotide-binding oligomerization domain-like receptors (NLR) family pyrin domain containing 3 (NLRP3) inflammasome. Med Sci Monit. 25:2718–2726. 2019.PubMed/NCBI View Article : Google Scholar

54 

Luo M, Yan D, Sun Q, Tao J, Xu L, Sun H and Zhao H: Ginsenoside Rg1 attenuates cardiomyocyte apoptosis and inflammation via the TLR4/NF-κB/NLRP3 pathway. J Cell Biochem. 121:2994–3004. 2020.PubMed/NCBI View Article : Google Scholar

55 

Gan P, Gao Z, Zhao X and Qi G: Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-κB and inflammasomes in macrophages for adjuvant activity. Sci Rep. 6(39303)2016.PubMed/NCBI View Article : Google Scholar

56 

Peng X, Yang Y, Tang L, Wan J, Dai J, Li L, Huang J, Shen Y, Lin L, Gong X and Zhang L: Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway. Biomed Pharmacother. 125(110020)2020.PubMed/NCBI View Article : Google Scholar

57 

Youn CK, Kim J, Jo ER, Oh J, Do NY and Cho SI: Protective effect of tempol against cisplatin-induced ototoxicity. Int J Mol Sci. 17(1931)2016.PubMed/NCBI View Article : Google Scholar

58 

Wilcox CS: Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther. 126:119–145. 2010.PubMed/NCBI View Article : Google Scholar

59 

Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Fórró L, Schlegel W and Krause KH: NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J. 406:105–114. 2007.PubMed/NCBI View Article : Google Scholar

60 

Barman J, Kumar R, Saha G, Tiwari K and Dubey VK: Apoptosis: Mediator molecules, interplay with other cell death processes and therapeutic potentials. Curr Pharm Biotechnol. 16:644–663. 2018.PubMed/NCBI View Article : Google Scholar

61 

Liu QS, Deng R, Li S, Li X, Li K, Kebaituli G, Li X and Liu R: Ellagic acid protects against neuron damage in ischemic stroke through regulating the ratio of Bcl-2/Bax expression. Appl Physiol Nutr Metab. 42:855–860. 2017.PubMed/NCBI View Article : Google Scholar

62 

Zhou H, Wang Q, Yuan D, Wang J, Huang Y, Wu H, Jian J, Yang D, Huang N, Haisch C, Jiang Z and Chen S: Early apoptosis real-time detection by label-free SERS based on externalized phosphatidylserine. Analyst. 141:4293–4298. 2016.PubMed/NCBI View Article : Google Scholar

63 

Qi C, Liu X, Xiong T and Wang D: Tempol prevents isoprenaline-induced takotsubo syndrome via the reactive oxygen species/mitochondrial/anti-apoptosis/p38 MAPK pathway. Eur J Pharmacol. 886(173439)2020.PubMed/NCBI View Article : Google Scholar

64 

Ju Y, Su Y, Chen Q, Ma K, Ji T, Wang Z and Li W and Li W: Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats. Biomed Pharmacother. 109:84–92. 2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Y, Ding S, Chen Y, Sun Z, Zhang J, Han Y, Dong X, Fang Z and Li W: Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Exp Ther Med 22: 782, 2021.
APA
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y. ... Li, W. (2021). Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Experimental and Therapeutic Medicine, 22, 782. https://doi.org/10.3892/etm.2021.10214
MLA
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y., Dong, X., Fang, Z., Li, W."Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells". Experimental and Therapeutic Medicine 22.1 (2021): 782.
Chicago
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y., Dong, X., Fang, Z., Li, W."Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells". Experimental and Therapeutic Medicine 22, no. 1 (2021): 782. https://doi.org/10.3892/etm.2021.10214
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Ding S, Chen Y, Sun Z, Zhang J, Han Y, Dong X, Fang Z and Li W: Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Exp Ther Med 22: 782, 2021.
APA
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y. ... Li, W. (2021). Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells. Experimental and Therapeutic Medicine, 22, 782. https://doi.org/10.3892/etm.2021.10214
MLA
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y., Dong, X., Fang, Z., Li, W."Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells". Experimental and Therapeutic Medicine 22.1 (2021): 782.
Chicago
Zhang, Y., Ding, S., Chen, Y., Sun, Z., Zhang, J., Han, Y., Dong, X., Fang, Z., Li, W."Ginsenoside Rg1 alleviates lipopolysaccharide‑induced neuronal damage by inhibiting NLRP1 inflammasomes in HT22 cells". Experimental and Therapeutic Medicine 22, no. 1 (2021): 782. https://doi.org/10.3892/etm.2021.10214
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team